NASDAQ:GBT - Global Blood Therapeutics, Inc.
$54.85
 $-1.74
-3.07%
4:00PM EDT
2019-04-18
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The Company is evaluating GBT440 in SCD in a Phase III clinical trial of GBT440 in adult and adolescent patients with SCD. GBT440 inhibits abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. The Company is also engaged in other research and development activities targeted towards hereditary angioedema (HAE). The Company's GBT440 is an investigational drug that increases hemoglobin's affinity for oxygen by binding to the alpha-chain of hemoglobin. GBT440 has been observed to keep a proportion of sickle hemoglobin (HbS), in its oxygenated state, where it cannot participate in polymerization. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  GBT     avg for
industry  
  avg for
sector  
42 stocks weight:  261. 53   199. 07   233. 87  
42 stocks rank:  814. 00   1. 43 K 1. 06 K
# analyst opinions:  13. 00   14. 48   14. 09  
mean recommendation:  1. 70   2. 09   2. 01  

quick ratio:  14. 14   5. 29   1. 92  
current ratio:  14. 38   5. 64   2. 40  

target price low:  57. 00   84. 50   115. 74  
target price avg:  88. 23   110. 73   137. 39  
target price high:  150. 00   136. 41   157. 80  
1-yr high:  59. 08   114. 11   138. 85  
last close:  54. 85   87. 56   116. 78  
50-day avg:  53. 07   95. 43   123. 53  
200-day avg:  44. 54   94. 13   121. 20  
1-yr low:  31. 54   72. 67   98. 41  
volume:  486. 10 K 2. 43 M 4. 85 M
50-day avg volume:  643. 62 K 2. 72 M 4. 97 M
200-day avg volume:  935. 95 K 2. 90 M 4. 58 M

1-day return:  -3. 07 % -0. 40 % 0. 07 %
this week return:  -7. 07 % -5. 72 % -4. 11 %
12-wk return:  17. 05 % 1. 78 % -0. 04 %
52-wk return:  30. 42 % 10. 81 % 14. 09 %

enterprise value (EV):  2. 85 B 51. 19 B 117. 96 B
market cap:  3. 09 B 43. 00 B 104. 52 B
EBITDA:  -180. 44 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -15. 79   4. 34   13. 27  
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -174. 19 M 2. 20 B 4. 21 B

shares outstanding:  56. 32 M 570. 91 M 1. 24 B
shares:  49. 29 M 571. 02 M 1. 23 B
shares short:  8. 00 M 9. 93 M 16. 79 M
shares short prior month:  7. 93 M 9. 96 M 16. 58 M
short ratio:  10. 56   5. 31   3. 30  
short % of float:  17. 92 % 5. 81 % 2. 61 %
total cash/share:  8. 48   11. 13   9. 30  
total cash:  477. 53 M 6. 70 B 7. 10 B
free cash flow:  -77. 90 M 3. 58 B 4. 74 B
operating cash flow:  -135. 38 M 4. 14 B 6. 32 B

book value:  10. 29   12. 76   26. 84  
price/book:  5. 33   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  47. 81 % --- ---
1-yr mean volatility:  0. 17 % 0. 03 % 0. 04 %

1-yr EPS:  -3. 40   2. 39   4. 08  
forward EPS:  -3. 07   3. 97   7. 14  
P/E:  -16. 11   13. 59   22. 83  
forward P/E:  -19. 22   -20. 05   14. 49  
PE/G:  3. 13   -1. 46   1. 68  
growth:  -5. 15 % 126. 81 % 29. 29 %
earnings high:  -0. 74   1. 02   1. 63  
earnings avg:  -0. 94   0. 76   1. 51  
earnings low:  -1. 13   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -23. 44 % -2. 80 % 5. 29 %
return on equity:  -39. 07 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  1. 74   1. 24   0. 93  
sharpe (1yr):  0. 58   0. 29   0. 60  

held % insiders:  62. 29 % 6. 38 % 3. 38 %
held % institutions:  13. 19 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : GBT
.    + 4.001 =         4.001 :: INITIAL WEIGHT
.   + 53.757 =        57.758 :: inverse volume-to-price addition
.   + 46.119 =       103.877 :: spline projection addition
.    x 4.744 =       492.774 :: 13 weeks' performance factor
.    x 1.194 =       588.218 :: one-year gains+dividend factor
.    x 1.432 =       842.343 :: industry recommendation factor
.    x 2.934 =      2471.063 :: symbol recommendation factor
.    x 0.998 =       2465.27 :: return on assets factor
.    x 0.996 =      2455.637 :: return on equity factor
.    x 2.551 =      6264.434 :: current ratio factor
.    x 1.037 =      6498.436 :: quick ratio factor
.    x 1.046 =      6799.168 :: short ratio factor
.    x 2.079 =     14136.467 :: price-to-book factor
.    x 1.285 =     18170.801 :: 5-day avg > 200-day avg
.    x 1.079 =     19600.783 :: 5-day avg > 50-day avg
.    x 1.192 =     23356.474 :: 50-day avg > 200-day avg
.     x 1.81 =     42275.223 :: P/E weight
.    x 0.752 =     31791.985 :: PE/G factor
.    x 1.413 =     44912.157 :: beta factor
.    x 0.579 =     25998.515 :: sharpe factor
.    x 1.196 =     31094.462 :: target low factor
.     x 1.26 =     39180.143 :: target mean factor
.    x 1.132 =     44340.528 :: target high factor
.    x 1.312 =     58159.183 :: industry 2-weeks return factor
.    x 0.951 =     55326.633 :: "drift" penalty 2 days ago
.    x 0.948 =     52462.756 :: "drift" penalty 4 days ago
.    x 0.947 =     49699.003 :: "drift" penalty 5 days ago
.    x 0.995 =     49458.761 :: overall "drift" factor
.    x 0.522 =     25811.393 :: largest single-day jump factor
.     x 1.01 =     26069.078 :: mean volatility factor
.    x 1.098 =     28624.856 :: 42-day mean volatility factor
.      x 1.0 =     28620.242 :: factor hist industry gain for week 15
.   cubeRoot =        30.588 :: reduced to standardize
.  + 230.945 =       261.533 :: add/subtract for performance
.                    261.533 :: FINAL WEIGHT for NASDAQ:GBT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org